Facility # 2
3331 West River Drive
Philadelphia, Pennsylvania 19104

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Thyroid Cancer Clinical Trial
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile
Status: Enrolling, Phase II
Updated: 12/31/1969
Facility # 2
mi
from
Philadelphia, PA
Click here to add this to my saved trials